In a clinical trial, six patients had no consanguinity with non‐recurrent deletions in 6q22.1 region including NUS1 and established that the loss of this region results in a neurodevelopmental disorder with clinical features such as epilepsy, cognitive deficits, language delay and variable kinds of tremors.79 Here, NUS1 is linked to neurodevelopmental disorder.